Accord BioPharma
Ricky Dyer currently serves as Senior Director of Market Access at Accord BioPharma, a position held since May 2024. Prior experience includes roles at Cardinal Health as National Sales Director for Urology and Business Development Director for Oncology/Urology, achieving the 2022-23 Business Development Director of The Year for generating over $150 million in new annual sales. Ricky’s background also includes significant contributions at Merck as a GU Oncology Sales Representative, where responsibilities included launching Keytruda, and at Spectrum Pharmaceuticals, Inc. as an Oncology Account Manager. Additional experience encompasses sales roles at Stryker, Amgen, Ortho-McNeil Pharmaceutical, Newell Rubbermaid, and military service in the United States Marine Corps. Ricky holds a degree in Communication, specializing in Speech Communication, from the University of Tennessee, Knoxville.
Accord BioPharma
We see things from the patients' perspective and believe what comes before and after a drug is just as important as the drug itself. We go #BeyondBiology